rs28491316

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000498.3(CYP11B2):​c.*735G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.353 in 152,058 control chromosomes in the GnomAD database, including 11,378 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.35 ( 11370 hom., cov: 31)
Exomes 𝑓: 0.39 ( 8 hom. )

Consequence

CYP11B2
NM_000498.3 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.787

Publications

8 publications found
Variant links:
Genes affected
CYP11B2 (HGNC:2592): (cytochrome P450 family 11 subfamily B member 2) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the mitochondrial inner membrane. The enzyme has steroid 18-hydroxylase activity to synthesize aldosterone and 18-oxocortisol as well as steroid 11 beta-hydroxylase activity. Mutations in this gene cause corticosterone methyl oxidase deficiency. [provided by RefSeq, Jul 2008]
GML (HGNC:4375): (glycosylphosphatidylinositol anchored molecule like) Predicted to be involved in DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; apoptotic process; and negative regulation of cell population proliferation. Predicted to be extrinsic component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 8-142911245-C-T is Benign according to our data. Variant chr8-142911245-C-T is described in ClinVar as Benign. ClinVar VariationId is 362180.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.447 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000498.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP11B2
NM_000498.3
MANE Select
c.*735G>A
3_prime_UTR
Exon 9 of 9NP_000489.3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP11B2
ENST00000323110.2
TSL:1 MANE Select
c.*735G>A
3_prime_UTR
Exon 9 of 9ENSP00000325822.2
CYP11B2
ENST00000945895.1
c.*735G>A
3_prime_UTR
Exon 9 of 9ENSP00000615954.1
CYP11B2
ENST00000945896.1
c.*735G>A
3_prime_UTR
Exon 9 of 9ENSP00000615955.1

Frequencies

GnomAD3 genomes
AF:
0.353
AC:
53631
AN:
151844
Hom.:
11374
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.113
Gnomad AMI
AF:
0.520
Gnomad AMR
AF:
0.416
Gnomad ASJ
AF:
0.541
Gnomad EAS
AF:
0.316
Gnomad SAS
AF:
0.402
Gnomad FIN
AF:
0.483
Gnomad MID
AF:
0.421
Gnomad NFE
AF:
0.451
Gnomad OTH
AF:
0.389
GnomAD4 exome
AF:
0.385
AC:
37
AN:
96
Hom.:
8
Cov.:
0
AF XY:
0.393
AC XY:
22
AN XY:
56
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
2
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.500
AC:
4
AN:
8
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.389
AC:
28
AN:
72
Other (OTH)
AF:
0.417
AC:
5
AN:
12
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.353
AC:
53620
AN:
151962
Hom.:
11370
Cov.:
31
AF XY:
0.358
AC XY:
26599
AN XY:
74258
show subpopulations
African (AFR)
AF:
0.113
AC:
4690
AN:
41508
American (AMR)
AF:
0.416
AC:
6354
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.541
AC:
1875
AN:
3468
East Asian (EAS)
AF:
0.314
AC:
1615
AN:
5142
South Asian (SAS)
AF:
0.403
AC:
1929
AN:
4788
European-Finnish (FIN)
AF:
0.483
AC:
5089
AN:
10542
Middle Eastern (MID)
AF:
0.412
AC:
121
AN:
294
European-Non Finnish (NFE)
AF:
0.451
AC:
30665
AN:
67938
Other (OTH)
AF:
0.386
AC:
812
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1579
3158
4738
6317
7896
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
516
1032
1548
2064
2580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.419
Hom.:
35333
Bravo
AF:
0.337
Asia WGS
AF:
0.310
AC:
1079
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
Corticosterone 18-monooxygenase deficiency (1)
-
-
1
Corticosterone methyloxidase type 2 deficiency (1)
-
-
1
Glucocorticoid-remediable aldosteronism (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
1.4
DANN
Benign
0.62
PhyloP100
-0.79
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28491316; hg19: chr8-143992661; API